Article
Human Embryonic Stem Cells Possess Immune‐Privileged Properties
1 Jul 2004
Abstract excerpt
Human embryonic stem cells (hESCs) are envisioned to be a major source for cell-based therapies. Efforts to overcome rejection of hESCs include nuclear transfer and collection of hESC banks representing the broadest diversity of major histocompatability complex (MHC) polymorphorisms. Surprisingly, immune responses to hESCs have yet to be experimentally evaluated. Here, injection of hESCs into immune-competent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
